论文部分内容阅读
目的:总结胃炎合剂联合莫沙比利治疗慢性萎缩性胃炎的临床效果。方法:在统计学原理的指导下将我院2014年9月-2015年9月收治的慢性萎缩性胃炎患者78例作为本次研究活动的对象。并将其分为例数均等的对照组和观察组。对照组患者单纯使用胃炎合剂进行治疗。观察组患者在对照组患者治疗的基础上联合莫沙比利进行治疗,比较两组患者临床治疗效果。结果:治疗结果显示,观察组患者治疗总有效率92.3%高于对照组74.4%,数据符合统计学差异(P<0.05);与此同时,观察组患者上腹部疼痛、暖气以及腹胀等临床症状改善效果显著于对照组,数据符合统计学差异(P<0.05)。结论:在治疗慢性萎缩性胃炎的时候,相对于单纯的莫沙比利治疗措施,联合胃炎合剂展开治疗,效果更为显著,且还可有效改善患者的临床症状,促进患者康复。
Objective: To summarize the clinical effect of gastrogavage combined with mosapride on chronic atrophic gastritis. Methods: According to the principle of statistics, 78 patients with chronic atrophic gastritis who were treated in our hospital from September 2014 to September 2015 were selected as the research object. And divided into equal number of cases of control group and observation group. Patients in the control group were treated with gastritis alone. Patients in the observation group were treated with mosapride on the basis of the treatment of the control group, and the clinical effects of the two groups were compared. Results: The treatment results showed that the total effective rate of observation group was 92.3% higher than 74.4% of the control group, the data were in good agreement with statistical significance (P <0.05); meanwhile, the clinical symptoms such as upper abdominal pain, heating and bloating in observation group The improvement effect was significant in the control group, the data accord with the statistics difference (P <0.05). Conclusion: In the treatment of chronic atrophic gastritis, compared with the simple mosapride treatment, combined with gastritis mixture to start treatment, the effect is more significant, and can effectively improve the patient’s clinical symptoms and promote patient rehabilitation.